Benzinga | Aug 10, 2020 04:01PM EDT

Forte Biosciences, Inc. - Common Stock Q2 EPS $(9.52) Down From $(0.30) YoY

Forte Biosciences, Inc. - Common Stock (NASDAQ:FBRX) reported quarterly losses of $(9.52) per share. This is a 3073.33 percent decrease over losses of $(0.30) per share from the same period last year.